glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated dpp-4_inhibitors [TUSOM Complete pharmacology and pharmacotherapy of

GLP-1 helped reduce cravings and gave me more control over my meals

Patients who develop NAION may have permanent, irreversible vision loss and are encouraged to seek legal consultation

1,2 For this reason, its important to further understand the mechanism of GLP-1 therapies, said Lorenzo Leggio, a neuroendocrinologist at the National Institute on Drug Abuse who mediated the GLP-1 press conference at the 2025 Society for Neuroscience meeting

Mounjaro/Zepbound (tirzepatide) is a GLP1/GIP dual agonist (~2022.5% loss)

One of the key features of neuropathic pain is central sensitization, where the CNS becomes hyper-responsive to pain stimuli [105]